We are live on ! Find out more
ISPC icon

iSpecimen
ISPC

7 hedge funds and large institutions have $8.1M invested in iSpecimen in 2021 Q2 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0.02% more ownership

Funds ownership: 0% → 0.02% (+0.02%)

Holders
7
Holders Change
+7
Holders Change %
–
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BL
Bleichroeder LP
New York
+$4.32M
2
NAM
NewGen Asset Management
Ontario, Canada
+$1.8M
3
KC
Kepos Capital
New York
+$1.62M
4
Jane Street
Jane Street
New York
+$207K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$86.4K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BL
1
Bleichroeder LP
New York
$4.33M +$4.32M +750 New
NAM
2
NewGen Asset Management
Ontario, Canada
$1.8M +$1.8M +313 New
KC
3
Kepos Capital
New York
$1.63M +$1.62M +281 New
Jane Street
4
Jane Street
New York
$208K +$207K +36 New
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$85K +$86.4K +15 New
LC
6
Lindbrook Capital
California
$36K +$34.5K +6 New
UBS Group
7
UBS Group
Switzerland
$3K +$5.76K +1 New

ISPC Hedge Fund Activity: Q2 2021 in Review

7 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q2 2021, worth a combined $8.1M.

Buyers outnumbered sellers: 7 funds opened new ISPC positions and 0 closed out — a net gain of 7 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Bleichroeder LP, opening a new position worth an estimated $4.32M.

  • 7 institutional investors held iSpecimen (ISPC) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $8.1M of iSpecimen stock for Q2 2021.
  • 7 funds opened new iSpecimen positions in Q2 2021 and 0 closed out, a net change of +7 holders.
  • The largest iSpecimen buyer in Q2 2021 was Bleichroeder LP, an estimated $4.32M added.

Based on aggregated 13F filings for Q2 2021.